Cargando…

HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Zong, Beige, Sun, Lu, Peng, Yang, Wang, Yihua, Yu, Yu, Lei, Jinwei, Zhang, Yingzi, Guo, Shipeng, Li, Kang, Liu, Shengchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317148/ https://www.ncbi.nlm.nih.gov/pubmed/34296290 http://dx.doi.org/10.3892/or.2021.8146

Ejemplares similares

HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance
por: Zong, Beige, et al.
Publicado: (2021)

Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells
por: Zhang, Yingzi, et al.
Publicado: (2021)

Ki67 Index Changes and Tumor-Infiltrating Lymphocyte Levels Impact the Prognosis of Triple-Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy
por: Wang, Yihua, et al.
Publicado: (2021)

HORMAD1 overexpression predicts response to anthracycline–cyclophosphamide and survival in triple‐negative breast cancers
por: El‐Botty, Rania, et al.
Publicado: (2023)

The role of taxanes in triple-negative breast cancer: literature review [Corrigendum]
Publicado: (2015)

Novel Breast-Specific Long Non-coding RNA LINC00993 Acts as a Tumor Suppressor in Triple-Negative Breast Cancer
por: Guo, Shipeng, et al.
Publicado: (2019)

Mouse HORMAD1 and HORMAD2, Two Conserved Meiotic Chromosomal Proteins, Are Depleted from Synapsed Chromosome Axes with the Help of TRIP13 AAA-ATPase
por: Wojtasz, Lukasz, et al.
Publicado: (2009)

Functional screening reveals HORMAD1-driven gene dependencies associated with translesion synthesis and replication stress tolerance
por: Tarantino, Dalia, et al.
Publicado: (2022)

Corrigendum to “GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol)”
Publicado: (2022)

Corrigendum to Hypoxia induces docetaxel resistance in triple-negative breast cancer via the HIF-1 α/miR-494/Survivin signaling pathway [Volume 32 Number xxx Month 2022 pp. 100821]
por: Li, Hongchang, et al.
Publicado: (2022)

Corrigendum to “Docetaxel-Induced Systemic Sclerosis with Internal Organ Involvement Masquerading as Congestive Heart Failure”
por: Park, Bumsoo, et al.
Publicado: (2017)

Anti-Cancer Activity Based on the High Docetaxel Loaded Poly(2-Oxazoline)s Micelles [Corrigendum]
Publicado: (2021)

Corrigendum to “Expression of Intratumoral IGF-II Is Regulated by the Gene Imprinting Status in Triple Negative Breast Cancer from Vietnamese Patients”
por: Radhakrishnan, Vinodh Kumar, et al.
Publicado: (2018)

Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer
por: Gil, Eun Young, et al.
Publicado: (2017)

Synergistic Effect Of A Retinoid X Receptor-Selective Ligand Bexarotene And Docetaxel In Prostate Cancer [Corrigendum]
Publicado: (2019)

SPOC1 modulates DNA repair by regulating key determinants of chromatin compaction and DNA damage response
por: Mund, Andreas, et al.
Publicado: (2020)

Aberrantly expressed HORMAD1 disrupts nuclear localization of MCM8–MCM9 complex and compromises DNA mismatch repair in cancer cells
por: Liu, Kang, et al.
Publicado: (2020)

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer
por: Al-Ejeh, F, et al.
Publicado: (2014)

Corrigendum to: Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130)
por: Iwata, Hiroji, et al.
Publicado: (2020)

HORMAD2 methylation‐mediated epigenetic regulation of gene expression in thyroid cancer
por: Lin, Qiuyu, et al.
Publicado: (2018)

Methyl methanesulfonate (MMS) produces heat-labile DNA damage but no detectable in vivo DNA double-strand breaks
por: Lundin, Cecilia, et al.
Publicado: (2012)

Using CdTe/ZnSe Core/Shell Quantum Dots to Detect DNA and Damage to DNA [Corrigendum]
Publicado: (2022)

Assessment of the Predictive Role of Serum Lipid Profiles in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Qu, Fanli, et al.
Publicado: (2020)

Although c-MYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ER-positive breast cancer
por: Chen, Rui, et al.
Publicado: (2020)

Dub3 controls DNA damage signalling by direct deubiquitination of H2AX
por: Delgado‐Díaz, M. Rocío, et al.
Publicado: (2017)

In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts [Corrigendum]
Publicado: (2019)

Construction and Validation of an Immune Infiltration-Related Gene Signature for the Prediction of Prognosis and Therapeutic Response in Breast Cancer
por: Peng, Yang, et al.
Publicado: (2021)

The Cancer/Testes (CT) Antigen HORMAD1 promotes Homologous Recombinational DNA Repair and Radioresistance in Lung adenocarcinoma cells
por: Gao, Yanzhe, et al.
Publicado: (2018)

Molecular structure of a U•A-U-rich RNA triple helix with 11 consecutive base triples
por: Ruszkowska, Agnieszka, et al.
Publicado: (2020)

A transcriptional factor B paralog functions as an activator to DNA damage-responsive expression in archaea
por: Feng, Xu, et al.
Publicado: (2018)

Epigenetic activation of HORMAD1 in basal-like breast cancer: role in Rucaparib sensitivity
por: Wang, Xian, et al.
Publicado: (2018)

A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma
por: Peng, Yang, et al.
Publicado: (2021)

An E2F7-dependent transcriptional program modulates DNA damage repair and genomic stability
por: Mitxelena, Jone, et al.
Publicado: (2019)

Nuclear factor-κB signaling negatively regulates high glucose-induced vascular endothelial cell damage downstream of the extracellular signal-regulated kinase/c-Jun N-terminal kinase pathway
por: Chen, Yunzhi, et al.
Publicado: (2018)

Downregulation of β3 integrin by miR-30a-5p modulates cell adhesion and invasion by interrupting Erk/Ets-1 network in triple-negative breast cancer
por: Li, Wentong, et al.
Publicado: (2021)

Degradation of DNA damage-independently stalled RNA polymerase II is independent of the E3 ligase Elc1
por: Karakasili, E., et al.
Publicado: (2015)

Phospho-epitope binding by the BRCT domains of hPTIP controls multiple aspects of the cellular response to DNA damage
por: Munoz, Ivan M., et al.
Publicado: (2017)

Netrin-1 induces the proliferation of gastric cancer cells via the ERK/MAPK signaling pathway and FAK activation
por: Yin, Kai, et al.
Publicado: (2019)

Corrigendum to “Cerium Oxide Nanoparticles Induced Toxicity in Human Lung Cells: Role of ROS Mediated DNA Damage and Apoptosis”
por: Mittal, Sandeep, et al.
Publicado: (2018)

Boron Neutron Capture Therapy Eliminates Radioresistant Liver Cancer Cells by Targeting DNA Damage and Repair Responses [Corrigendum]
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r58hc1rs5652bq6r8ehsas789f